Adjuvant treatment for older women with invasive breast cancer

Women's Health
Trevor A JollyHyman B Muss

Abstract

Older women experience a large share of breast cancer incidence and death. With the projected rise in the number of older cancer patients, adjuvant chemo-, radiation and endocrine therapy management will become a key component of breast cancer treatment in older women. Many factors influence adjuvant treatment decisions including patient preferences, life expectancy and tumor biology. Geriatric assessment predicts important outcomes, identifies key deficits, and can aid in the decision making process. This review utilizes clinical vignettes to illustrate core principles in adjuvant management of breast cancer in older women and suggests an approach incorporating life expectancy and geriatric assessment.

References

Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Dec 7, 1994·Journal of the National Cancer Institute·S B YellenW T Leslie
Apr 6, 2000·Journal of the National Cancer Institute·S G DiabG M Clark
Apr 5, 2002·The New England Journal of Medicine·Terri R FriedHeather Allore
Aug 8, 2002·Journal of the National Cancer Institute·Timothy WhelanBarbara Szechtman
Jun 13, 2003·The New England Journal of Medicine·Ian E Smith, Mitch Dowsett
Jul 26, 2003·BMJ : British Medical Journal·Paul GlareNicholas Christakis
Dec 4, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Martine Extermann
Sep 3, 2004·The New England Journal of Medicine·Anthony W FylesIvo A Olivotto
Sep 3, 2004·The New England Journal of Medicine·Kevin S HughesUNKNOWN Eastern Cooperative Oncology Group
Mar 3, 2005·JAMA : the Journal of the American Medical Association·Hyman B MussUNKNOWN Cancer and Leukemia Group B
May 10, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·John YarnoldRoger Owen
Aug 9, 2005·Critical Reviews in Oncology/hematology·Martine ExtermannUNKNOWN Task Force on CGA of the International Society of Geriatric Oncology
Jan 6, 2006·The Cancer Journal·Rishi SawhneyArash Naeim
Feb 16, 2006·JAMA : the Journal of the American Medical Association·Sei J LeeKenneth E Covinsky
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithAntonio C Wolff
May 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Soonmyung PaikNorman Wolmark
Dec 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen E JonesLina Asmar
Jan 16, 2007·Breast Cancer Research and Treatment·Regan A HowardLois B Travis
Jun 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria E HewittCatherine Harvey
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary C PinderSharon H Giordano
Feb 14, 2008·Journal of the National Cancer Institute·Judith-Anne W ChapmanPaul E Goss
Apr 1, 2008·Critical Reviews in Oncology/hematology·Jay F PiccirilloEwout W Steyerberg
Aug 13, 2008·Journal of the National Cancer Institute·Abenaa M BrewsterFrancisco J Esteva
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen JonesMichael A Savin
May 15, 2009·The New England Journal of Medicine·Hyman B MussUNKNOWN CALGB Investigators
Aug 28, 2009·Critical Reviews in Oncology/hematology·Claire RobbMartine Extermann
Dec 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitch DowsettRichard Peto
Feb 12, 2010·The New England Journal of Medicine·Timothy J WhelanCarolyn Freeman
Mar 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arti HurriaHarvey Jay Cohen
Jul 12, 2011·Journal of the National Cancer Institute·Eitan AmirAlberto Ocaña
Jul 30, 2011·Journal of the American Geriatrics Society·Mara A SchonbergEdward R Marcantonio
Aug 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arti HurriaWilliam P Tew

❮ Previous
Next ❯

Citations

Jan 23, 2019·Cancer·Michael W Parsons, Jorg Dietrich
Apr 30, 2019·Scandinavian Journal of Medicine & Science in Sports·Ann Christin Helgesen BjørkeSveinung Berntsen
Mar 3, 2018·The Journal of Sports Medicine and Physical Fitness·Gabriele MascheriniGiorgio Galanti
May 16, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Marlon OsorioCristina Castro
Dec 3, 2016·The Breast Journal·Jesus Anampa, Joseph A Sparano
Apr 6, 2021·World Journal of Biological Chemistry·Rama Rao MallaGanji Purnachandra Nagaraju
Jun 28, 2021·Breast Cancer Research and Treatment·Jeffrey E JohnsonStephanie Downs-Canner

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

! Online
Medscape
Predict
Adjuvant
ePrognosis

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen
H Sauer, W Wilmanns
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer
R D Gelber
Cancer Treatment and Research
Rosalba Torrisi
© 2022 Meta ULC. All rights reserved